The Atlas / Regulations
Rules that apply to clinics and products
One record for each instrument in each market. Every record links to the regulator's own text and shows the date the Atlas read it. A record marked Checked was read in its primary source; a record marked WATCH is an instrument that is pending or unsettled, with what is known. The Atlas states what an instrument says and does not give legal advice. 23 records across 18 markets, 2 of them on watch.
Asia1
ASEAN Medical Device Directive
Sets common essential principles and risk classification rules for medical devices, and enters into force only among member states that have accepted it under their own domestic requirements.
Canada1
Canada Health Act, sections 18 and 19, extra-billing and user charges
Defines extra-billing as billing for an insured health service above what a provincial health care insurance plan pays, and the Act's sections 18 and 19 deal with extra-billing and user charges.
Denmark1
Hospital exemption under Article 28 of Regulation (EC) No 1394/2007
Defines the hospital exemption as an advanced therapy medicinal product prepared on a non-routine basis and used in a hospital in the same Member State under a medical practitioner's responsibility for an individual patient.
Germany1
Section 4b Arzneimittelgesetz (German Medicines Act), non-routinely produced advanced therapy medicinal products
Names the Paul-Ehrlich-Institut as the authority that authorises non-routinely manufactured advanced therapy medicinal products under section 4b (3) of the German Medicines Act.
Hong Kong SAR1
Private Healthcare Facilities Ordinance (Cap. 633), clinic licence and small practice exemption
Clinics operating on 30 November 2018 could apply for a provisional clinic licence between 13 October 2025 and 13 April 2026.
Italy2
Decree of 16 January 2015 on advanced therapy medicinal products prepared on a non-repetitive basis
Sets provisions for advanced therapy medicinal products prepared on a non-repetitive basis, as its title states.
Legislative Decree 502/1992, article 8-ter, authorization of healthcare facilities
Requires an authorization to build a healthcare structure and a separate authorization to operate it, and has the regions set the procedures and terms for requesting them.
Japan3
Act No. 51 of 2024, amendment of the Act on the Safety of Regenerative Medicine and the Clinical Trials Act
The notice says the amending Act was promulgated on 14 June 2024 to be enforced in stages, and extends the safety law to gene therapy that does not use processed cells.
Act on the Safety of Regenerative Medicine
Requires a provision plan for regenerative medicine to be submitted and reviewed by a certified committee, and sets rules for manufacturing cells for it.
Medical Care Act, Article 8, notification to open a clinic
Requires a clinically trained physician, dentist or midwife who establishes a clinic or birthing center to notify the prefectural governor within ten days of its establishment.
Middle East1
GCC centralized registration, Resolution No. 6 of the 45th conference
Runs a central registration of medicines for the member states, approved by Resolution No. 6 of the council's forty-fifth conference held in Geneva in May 1998.
Saudi Arabia2
Guideline on Classification of Advanced Therapy Medicinal Products, Version 1.0
Gives the Saudi Food and Drug Authority's classification of advanced therapy medicinal products, issued 6 November 2023.
Healthcare Investor Licensing Guide
Guides investors through licensing healthcare facilities, from hospitals to laboratories; the guide names no longevity facility type.
Singapore1
List of specified services under the Healthcare Services Act
Lists each licensable healthcare service, such as the Outpatient Medical Service, with the modes of service delivery allowed for it; the list names no longevity service.
South Korea2
Bioethics and Safety Act
Defines genetic testing as analyzing chromosomes or genes from samples such as blood, hair or saliva to identify a person or test for a disease or predisposition, and regulates genetic testing and genetic data.
Medical Service Act
Is the Act that governs medical institutions in Korea, including clinics and hospitals.
Sweden1
Patient Safety Act (patientsakerhetslagen), duty to notify new or changed healthcare services
A provider that intends to start a service under IVO supervision must notify IVO at least one month before it starts, and report a change or closure within one month.
Switzerland1
Legal basis governing the use of tissues and cells of human origin (Therapeutic Products Act and Transplantation Act)
Says use of human tissues and cells is subject to principles and restrictions under the Transplantation Act and the Therapeutic Products Act, and that a Swissmedic establishment licence or authorisation may be needed.
United Arab Emirates2
Healthy Longevity Medicine Clinic Standard
Sets the minimum requirements for healthy longevity medicine clinic services in the Emirate of Abu Dhabi, for facilities licensed by the Department of Health to provide them.
Standards for Stem Cells and Regenerative Medicine
Sets the standards for stem cell and regenerative medicine services, issued 20 February 2025 by the Health Regulation Sector.
United Kingdom1
Guidance on the UK hospital exemption scheme for advanced therapy medicinal products (Human Medicines Regulation 2012)
Explains the arrangements for advanced therapy medicinal products made and used under the hospital exemption scheme in the UK, and says the guidance does not cover products authorised by marketing authorisation or supplied for a clinical trial.
United States1
Laboratory developed tests: May 2024 final rule vacated, text reverted
The FDA's page says its 6 May 2024 final rule on laboratory developed tests was vacated by a federal district court on 31 March 2025 and that on 19 September 2025 it issued a final rule reverting the regulation to its earlier text.
Vietnam1
Law on Medical Examination and Treatment
Requires practice competence assessment for physicians from 1 January 2027, for nurses, midwives and medical assistants from 1 January 2028, and for other titles from 1 January 2029.